WFSBP 2019 Final Program

56 Scientific Program / Thursday, 6 June 2019 WFSBP 2019 THU T1: ADDICTIVE DISORDERS S-69 SYMPOSIUM 08:15–09:45 East Meeting Room 7 Ketamine: From basic to clinical Chair: Shih-Ku Lin, Taiwan Co-Chair: Kazutaka Ikeda, Japan 001 Involvement of NMDA receptor GluN2D subunit in ketamine effects Kazutaka Ikeda, Japan 002 Antidepressant effects of ketamine and its metabo- lites Kenji Hashimoto, Japan 003 The psychological consequences of chronic and heavy use of ketamine Ming-Chyi Huang, Taiwan 004 Ketamine dependence: Clinical features and man- agement Shih-Ku Lin, Taiwan T34: OBSESSIVE-COMPULSIVE DISORDERS: BASIC/CLINICAL WS-09 WORKSHOP 08:15–09:45 East Meeting Room 16 The three dimensions of refractory Obsessive- Compulsive Disorder: Clinical, neurobiological and therapeutical issues Chair: Enrique Galli, Peru Co-Chair: Andrea Marquéz Lopez Mato, Argentina 001 Genetic issues regarding OCD Alejo Corrales, Argentina 002 Neurobiological issues regarding OCD Andrea Marquéz Lopez Mato, Argentina 003 Therapeutic issues regarding TOC. TMS Enrique Galli, Peru FC-05 FREE COMMUNICATION SESSION 08:15–09:45 East Meeting Room 8/15 Bipolar disorders / Anxiety disorders / Addictions Chair: Soraya Seedat, South Africa 001 TNF-alpha and IL-6 in alcohol use disorder: A systematic review and meta-analysis Helena Moura, Brazil F. Hansen, D. Silvello, F. Galland, F. Rebellato, F. Ornell, R. Massuda, J. Scherer, F. Schuch, F. Kessler, L. von Diemen 002 Phenolic acids have anxiolytic effects in non-clini- cal human samples Emma Wightman, United Kingdom P. Jackson, D. Kennedy 003 Emotional memory and amygdala function and their correlation with childhood trauma and neuropro- gression in Bipolar Disorder (BD) Marcia Kauer-Sant´anna, Brazil A. Fijtman, D. Martins, J. Vinícius Pinto, I. Cavalcante Passos, J. Bücker 004 Brain age in Bipolar Disorders (BD): Effects of lithium treatment Holly van Gestel, Canada K. Franke, J. Petite, C. Slaney, J. Garnham, R. Uher, M. Alda, T. Hajek 005 Altered microglial morphology in prefrontal cortex in schizophrenia and Bipolar Disorder (BD) Clare Beasley, Canada C. Hercher, M. Tai, S. Hill FC-06 FREE COMMUNICATION SESSION 08:15–09:45 East Meeting Room 11 Consultation and liaison psychiatry Chair: TBC 003 COMT met/met genotype is associated with higher placebo response rates and pain tolerance in healthy men exposed to experimental pain Efrat Czerniak, Canada R. Treister, A. Citron, A. Ziv, O. Karnieli-Miller, M. Weiser, U. Alon, E. Eisenberg, D. Pud, A. Biegon 004 Cardiometabolic health: Where do we stand? Eval- uation of risk in a large psychiatric cohort and compari- son with a population-based sample in Switzerland Céline Dubath, Switzerland A. Delacretaz, A. Glatard, P. Vollenweider, M. Preisig, H. Richard-Lepouriel, F. Gamma, A. Solida, J. Thonney, S. Fassassi, A. von Gunten, P. Conus, C. B. Eap 005 Electroconvulsive treatment restores the decreased coverage of brain blood vessels by astrocytic endfeet and ameliorates depressive-like behavior Sadayuki Hashioka, Japan I. Azis, K. Tsuchie, R. Abdullah, R. Arauchi, S. Miura, K. Inoue, M. Hayashida, R. Wake, T. Miyaoka, M. Inagaki, M. Izuhara, M. Kanayama, K. Otsuki, M. Nagahama